Sherly Soleiman
Family Medicine · Encino, CANPI 1487858536
Payments from drug & device makers
Across 1,057 payments — averaging $1159.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.2M
- Lumenis BE Inc$2K
- Galderma Laboratories, L.p.$300
- Revance Therapeutics, Inc.$111
- Merz North America, Inc.$21
Across 1 payment — averaging $14.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$15
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 1,039 | $1,223,830 |
| Lumenis BE Inc | 1 | $1,500 |
| Galderma Laboratories, L.p. | 12 | $300 |
| Revance Therapeutics, Inc. | 4 | $111 |
| Merz North America, Inc. | 1 | $21 |
How this compares
$1,225,763 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Other family medicine in Encino
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.